T Naveh-Many, J Silver J Clin Invest. 1988;81(1):270-273. https://doi.org/10.1172/JCI113305. Calcitonin is secreted by the C cells of the thyroid in response to a raised serum calcium, and acts on bone to lower serum calcium. The C cells have specific receptors for the dihydroxymetabolite of vitamin D3, 1,25(OH)2D3. Moreover, calcitonin stimulates the synthesis of 1,25(OH)2D3 in the kidney. Parathyroid hormone (PTH), the third calciotrophic hormone, is also trophic to the renal synthesis of 1,25(OH)2D3, and in turn 1,25(OH)2D3 inhibits PTH gene transcription and synthesis. We report here the marked inhibition of calcitonin gene transcription by the injection of physiologically relevant doses of 1,25(OH)2D3 to normal rats that did not raise serum calcium. Calcitonin mRNA levels after 100 pmol 1,25(OH)2D3 decreased to 6% of basal at 6 h and 4% at 48 h, and a dose response showed a marked effect even after 12.5 pmol 1,25(OH)2D3, with no appreciably greater effect with larger doses (up to 200 pmol). Control genes, actin, thyroglobulin (thyroid follicular cells), somatostatin (thyroid C-cells) were not affected by 1,25(OH)2D3. Gel blots showed that 1,25(OH)2D3 decreased calcitonin mRNA levels without any change in its size. In vitro nuclear transcription showed that 1,25(OH)2D3-treated (100 pmol) rats' calcitonin transcription was 10% of control, while thyroglobulin and actin were 100%. We propose that calcium is the major regulator of PTH and calcitonin secretion, while 1,25(OH)2D3 is an important regulator of PTH […] Abstract Calcitonin is secreted by the C cells of the thyroid in response to a raised serum calcium, and acts on bone to lower serum calcium. The C cells have specific receptors for the dihydroxymetabolite of vitamin D3, 1,25(OH)2D3. Moreover, calcitonin stimulates the synthesis of 1,25(OH)2D3 in the kidney. Parathyroid hormone (PTH), the third calciotrophic hormone, is also trophic to the renal synthesis of 1,25(OH)2D3, and in turn 1,25(OH)2D3 inhibits PTH gene transcription and synthesis. We report here the marked inhibition of calcitonin gene transcription by the injection of physiologically relevant doses of 1,25(OH)2D3 to normal rats that did not raise serum calcium.
Introduction
Calcitonin, parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3)' are the three major hormones that determine calcium homeostasis. A low calcium stimulates PTH secretion and a high calcium calcitonin secretion, while both PTH and calcitonin are trophic to the synthesis of 1,25(OH)2D3 in the kidney. The major regulator of PTH gene transcription both in vitro and in vivo is 1,25(OH)2D3 (1, 2) . Feedback loops are a characteristic feature of hormone relationships and since calcitonin increases the synthesis of 1,25(OH)2D3 (3) (4) (5) by selectively stimulating the 25(OH)D3 1-hydroxylase enzyme in the proximal straight tubule of rat kidney nephron (6) , the question arose whether 1,25(OH)2D3 affected calcitonin production. 1,25(OH)2D3 acts on target cells like classical steroid hormones by binding to stereospecific high affinity receptors that then translocate to the nucleus to affect gene expression. In mammals, calcitonin is produced principally in the parafollicular or C cells of the thyroid gland that comprise less than 10% oftotal thyroid cells in rats (7) and 0.1% in adult humans (8) , therefore it would not be possible to detect the presence of 1,25(OH)2D3 receptors in whole thyroid cytosols. Medullary thyroid carcinomas are C cell carcinomas, which secrete calcitonin, and Freake and MacIntyre demonstrated the presence ofthe 1 ,25(OH)2D3-binding protein in the cytosol prepared from human medullary thyroid carcinomas (9) . The protein was not present in nordhal thyroid cytosols, probably reflecting the low proportion of C cells. The presence of 1,25(OH)2D3-binding protein in C cells suggests that they might be a target site for 1,25(OH)2D3. The effect of injected 1,25(OH)2D3 on serum calcitonin has produced conflicting results with small doses given to humans having no effect on calcitonin up to 2 h (10), while rats given large doses (1.2 nmol) had an increase in calcitonin at least partially due to hypercalcemia (1 1), or a decrease in the calcitonin response to calcium load together with a decrease in intrathyroidal calcitonin (12) . After a large dose of 1 ,25(OH)2D3 (500 pmol/200 g rat) Segond et al. (13) found no change in intrathyroidal calcitonin with a transient increase in calcitonin mRNA (1-2 h) that decreased at 4-16 h. We had shown in vivo in the rat that 1,25(OH)2D3 was a potent inhibitor of PTH gene transcription, reducing PTH mRNA levels by 75% and PTH nuclear transcription by 90% 24 h after a single injection of a small dose of 1 ,25(OH)2D3 (1) . For those experiments the thyroid and parathyroid were usually excised together, and RNA was extracted from both tissues for dot blot analysis of PTH mRNA. We have now rehybridized the same filters to study whether 1,25(OH)2D3 regulates calcitonin mRNA levels, and calcitonin gene transcription. The following control genes were used: actin for total thyroparathyroid tissue, thyroglobulin for thyroid follicular cells and somatostatin that like calcitonin, is localized to the C cells of the thyroid (14) . metabolites dissolved in propylene glycol (100 ,l) and at timed intervals the parathyroid-thyroid glands were excised in liquid nitrogen and stored at -20'C until extraction.
RNA extraction and hybridization. Total parathyroid-thyroid tissue RNA was prepared by extraction with guanidine thiocyanate and guanidine hydrochloride (15) and then spotted on nitrocellulose filters with and without further dilution for dot blot analysis. The filters were then hybridized with nick translated cDNA probes (2-5 X 108 cpm/,g), autoradiographed and the films scanned with a densitometer. The filters were extensively washed and then rehybridized with further probes. The calcitonin probe is an -900 bp cDNA (16) fragment. The thyroglobulin probe is a 640-bp cDNA fragment that represents part of the structural gene (17) . The somatostatin probe is a synthetic polynucleotide of 46 bp, and represents part of the somatostatin cDNA (18) .
The data for PTH mRNA and actin mRNA has been published previously (1) . For gel blot analysis, total RNA from thyroid-parathyroid tissue was extracted, denatured, and size fractionated by electrophoresis on 1.5% agarose gels containing formaldehyde and transferred to nitrocellulose filters by diffusion blotting (1) . RNA size was determined from the migration of ribosomal RNA markers. The same amounts ofRNA were run from control and 1,25(OH)2D3-treated rats, as quantitated by ethidium bromide staining and by spectrophotometry (OD260/OD28o = 2). Filters were hybridized sequentially with 32p nick translated cDNAs for preproPTH (1), calcitonin, and actin. Both in the dot blots and Northern blots the sequence of hybridization with different probes was random.
Nuclear transcription and RNA isolation. In vitro nuclear transcription run-offs were performed using 5 X 106 nuclei/ml, 200 MCi of [a-32P]UTP (400 Ci/mmol), and an incubation for 10 min at 26°C as previously described (1). The transcribed RNA was hybridized to filters prepared by spotting 5 Ag oflinearized denatured plasmid DNAs on nitrocellulose. Each dot of immobilized DNA was punched out from the filter strips and the radioactivity determined by liquid scintillation counting.
Results
1,25(OH)2D3 (100 pmol) led to a marked reduction in pre-proPTH mRNA reaching 50% at 6 h and 4% at 48 h (1). Calcitonin mRNA levels show an even more dramatic change in response to 1,25(OH)2D3 than PTH mRNA. At 6 h after 1,25(OH)2D3 injection calcitonin mRNA levels were 6% of basal, and 2% at 48 h (Fig. 1 ). There was no change in these same RNA tissue extracts for somatostatin mRNA, thyroglobulin mRNA, and actin mRNA, showing that there was no generalized decrease in mRNA levels. The constant amount of actin mRNA indicated that the RNA extraction did not vary. The response is concentration dependent but with a major effect on both PTH and calcitonin mRNAs at 12.5 pmol 1,25(OH)2D3 and little change from 50 to 200 pmol (Fig. 2) . The response is also metabolite specific with decreasing order of potency: 1,25(OH)2D3, 24,25(OH)2D3, 25(OH)2D3 vitamin D3 (results not shown). An agarose gel of extracted RNA (Northern blot) showed that from a 1,25(OH)2D3-treated rat the calcitonin mRNA was markedly reduced as compared with a control rat, while there was no effect on actin mRNA (Fig. 3 ). Both PTH mRNA (833 bp) (1) and calcitonin mRNA (900 bp) ran as single bands showing that the effect of 1,25(OH)2D3 was not on mRNA processing but on mRNA synthesis or degradation. In vitro nuclear transcription run-off experiments, in which transcription that had been initiated in vivo is elongated and completed in vitro, demonstrated that 1,25(OH)2D3 decreased calcitonin transcription to 10% of control, while thyroglobulin transcription was 100% of control ( Fig. 4) . We had previously shown that 1,25(OH)2D3 had no somatostatin, and fl-actin (not shown) were determined sequentially by hybridization with nick translated rat cDNA probes. The data for PTH mRNA has been published previously (1) . The results at each point are the mean±SE for four rats and expressed as a percentage of basal. effect on actin transcription but decreased PTH transcription to 10% of control (1) . This indicates that a major effect of 1,25(OH)2D3 is on calcitonin mRNA synthesis. The serum calciums were not elevated by the small single doses of 1,25(OH)2D3 injected to the rats.
Discussion
The action of 1,25(OH)2D3 is classically mediated by its action on the genome of target cells by either stimulating (e.g., calcium binding protein [19] , osteocalcin [20] , prolactin [211), or inhibiting transcription (e.g., collagen [22] , PTH [1] , C-myc oncogene [23]), and hence the synthesis of the respective proteins. The C cells of the thyroid that secrete calcitonin have receptors for 1,25(OH)2D3 (9), and we have now demonstrated that 1,25(OH)2D3 regulates calcitonin gene transcription, thus providing evidence that the C cell of the thyroid is a target organ for vitamin D. Somatostatin is also present only in thyroid C cells and not in thyroid follicular cells (14) . Somatostatin mRNA was not affected by 1,25(OH)2D3, demonstrating that the effect of 1,25(OH)2D3 is specific for the calcitonin gene. The thyroid follicular cells have no receptors for 1,25(OH)2D3 (9) and there was no change in thyroglobulin mRNA levels in response to 1,25(OH)2D3, confirming the specificity of the effect on the calcitonin gene. Calcitonin gene related peptide (CGRP) is derived from the same gene as calcitonin (24) , and therefore also might be regulated by 1 mM) on the in vitro production of calcitonin mRNA in rat thyroid slices. Up to 6 h there was no increase in calcitonin mRNA from calcium-stimulated thyroid slices, despite a linear increase in calcitonin secretion in response to calcium from similar thyroid preparations (26) . Therefore, calcium is the primary regulator of calcitonin secretion, but has not been shown to regulate calcitonin synthesis. In the present studies small physiologically relevant doses of 1,25(OH)2D3 (e.g., 12.5 pmol/150 g rat) were injected that had no effect on serum calcium, but reduced calcitonin mRNA by > 90% at 48 h, with a similar effect on PTH mRNA. In order to determine the importance of this effect in physiology further investigations are planned where small doses of 1,25(OH)2D3 will be injected into rats that would not affect the serum calcium, and circulating levels of PTH and calcitonin assayed. The results reported here together with our previous studies of the effect of 1,25(OH)2D3 on PTH gene regulation (1) indicate that while calcium concentration regulates PTH and calcitonin hormone secretion, 1,25(OH)2D3 is an important regulator of PTH and calcitonin gene transcription (Fig. 5 ).
